These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, Roth J. Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102 [Abstract] [Full Text] [Related]
12. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED. J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325 [Abstract] [Full Text] [Related]
13. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE. Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760 [Abstract] [Full Text] [Related]
14. Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis. Levälampi T, Honkanen V, Lahdenne P, Nieminen R, Hakala M, Moilanen E. Scand J Rheumatol; 2007 Dec; 36(3):189-93. PubMed ID: 17657672 [Abstract] [Full Text] [Related]